Form 4 for OM Outset Medical, Inc.
Accepted 2024-01-17 00:00:00 ET · period of report 2024-01-12 · accession 0001484612-24-000015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-01-17 | 2024-01-12 | OM | Brottem John L. | GC | A - Grant | $0.00 | +201.1K | 249.9K | +412% | $0 |
| 2024-01-17 | 2024-01-16 | OM | Brottem John L. | GC | S - Sale | $4.29 | -1,480 | 248.4K | -0.6% | -$6,349 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-12 | A | A | 96,000 | $0.00 | 144,807 | D | — | — | (F1) Represents restricted stock units ("RSU") granted to the reporting person on January 12, 2024. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on January 12, 2025, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date. |
| 2 | Common | Common Stock | 2024-01-12 | A | A | 100,000 | $0.00 | 244,807 | D | — | — | (F2) Represents performance-based restricted stock units ("PSUs") granted to the reporting person on January 12, 2024, that vest over a three year period based on the Issuer's common stock achieving specified prices per share, if not earlier vested upon satisfaction of specified performance criteria, subject to the reporting person's continuous service through the applicable vesting date. Each PSU represents a contingent right to receive one share of common stock. |
| 3 | Common | Common Stock | 2024-01-12 | A | A | 5,060 | $0.00 | 249,867 | D | — | — | (F3) On January 26, 2022, the reporting person was granted performance-based restricted stock units ("PSUs") subject to the satisfaction of specified performance criteria as of December 31, 2023. The reported amount represents the number of PSUs earned by the reporting person on January 12, 2024, upon certification by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria. Each PSU represents a contingent right to receive one share of common stock. These PSUs vested 50% on January 12, 2024, and the remaining 50% shall vest on December 31, 2024, subject to the reporting person's continuous service through the vesting date. |
| 4 | Common | Common Stock | 2024-01-16 | S | D | 1,480 | $4.29 | 248,387 | D | — | — | (F4) Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of PSUs on January 12, 2024 described in footnote (3) above. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. |